Evidence map

ReviewFunctional & integrative genomics2023

A review on CRISPR/Cas: a versatile tool for cancer screening, diagnosis, and clinic treatment.

Xianguang Yang et al.PubMed ↗Publisher ↗

No numbers read from the abstract.

23 papers cite it

2023
2024
2025
2026
this paperpooled itcites it
Full record →Abstract, authors, funding and every citing paper · PMID 37231285